IL90533A - 5-phenyl-8-nitro-2,3,4,5-tetrahydro-1h-3- benzazepine derivatives, their preparation and pharmaceutical compositions containing them - Google Patents

5-phenyl-8-nitro-2,3,4,5-tetrahydro-1h-3- benzazepine derivatives, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL90533A
IL90533A IL9053389A IL9053389A IL90533A IL 90533 A IL90533 A IL 90533A IL 9053389 A IL9053389 A IL 9053389A IL 9053389 A IL9053389 A IL 9053389A IL 90533 A IL90533 A IL 90533A
Authority
IL
Israel
Prior art keywords
bridge
benzazepines
hydroxy
hydrogen
benzazepine
Prior art date
Application number
IL9053389A
Other languages
English (en)
Other versions
IL90533A0 (en
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL90533A0 publication Critical patent/IL90533A0/xx
Publication of IL90533A publication Critical patent/IL90533A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL9053389A 1988-06-15 1989-06-05 5-phenyl-8-nitro-2,3,4,5-tetrahydro-1h-3- benzazepine derivatives, their preparation and pharmaceutical compositions containing them IL90533A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK325188A DK325188D0 (da) 1988-06-15 1988-06-15 Hidtil ukendte benzazepinderivater

Publications (2)

Publication Number Publication Date
IL90533A0 IL90533A0 (en) 1990-01-18
IL90533A true IL90533A (en) 1994-05-30

Family

ID=8120790

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9053389A IL90533A (en) 1988-06-15 1989-06-05 5-phenyl-8-nitro-2,3,4,5-tetrahydro-1h-3- benzazepine derivatives, their preparation and pharmaceutical compositions containing them

Country Status (15)

Country Link
US (2) US5010074A (es)
EP (1) EP0347672B1 (es)
JP (1) JP2769718B2 (es)
AT (1) ATE102188T1 (es)
AU (1) AU622911B2 (es)
CA (1) CA1317938C (es)
DE (1) DE68913367T2 (es)
DK (1) DK325188D0 (es)
ES (1) ES2061794T3 (es)
FI (1) FI93354C (es)
IE (1) IE891932L (es)
IL (1) IL90533A (es)
NO (1) NO173865C (es)
NZ (1) NZ229521A (es)
PT (1) PT90883B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK67489D0 (da) * 1989-02-14 1989-02-14 Novo Industri As Nye benzazepinderivater
US5158948A (en) * 1990-11-16 1992-10-27 Abbott Laboratories Tetracyclic spirobenzazepine dopamine antagonists
US5470850A (en) * 1992-02-24 1995-11-28 Novo Nordisk A/S 2,3,4,5-tetrahydro-1H-3-benzazepines
DK23392D0 (da) * 1992-02-24 1992-02-24 Novo Nordisk As Heterocykliske forbindelser, deres anvendelse og fremstilling
IL131670A (en) * 1997-03-12 2005-07-25 Addex Pharmaceuticals Sa Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders
US6277844B1 (en) 1998-09-14 2001-08-21 Sydney Spector Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis
GB0130576D0 (en) * 2001-12-20 2002-02-06 Cenes Ltd Dopamine D1 receptor agonist pro-drug compounds & derivatives
JP4555685B2 (ja) * 2002-08-29 2010-10-06 シェーリング コーポレイション 肥満およびｃｎｓ障害の処置のための選択的ｄ１／ｄ５レセプターアンタゴニスト
ATE441417T1 (de) 2002-12-20 2009-09-15 Glaxo Group Ltd Benzoädüazepinderivate für die behandlung von neurologischen krankheiten
WO2005035504A2 (en) * 2003-05-22 2005-04-21 Schering Corporation 5-h -benzo [d] naphth [2, 1-b] azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268243A (en) * 1968-03-11 1972-03-22 Wallace & Tiernan Inc 0,2,4,5,-tetrahydro-3h,3-benzazepines
US4210749A (en) * 1974-11-12 1980-07-01 Pennwalt Corporation Substituted 1,2,4,5-tetrahydro-3H,3 benzazepines
ZA792044B (en) * 1978-05-08 1980-05-28 Scherico Ltd Substituted 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof,and pharmaceutical compositions containing them
US4284556A (en) * 1980-01-31 1981-08-18 Smithkline Corporation 7,8-Amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4327023A (en) * 1980-01-31 1982-04-27 Smithkline Corporation Intermediates for preparing 7,8-amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
DK180485D0 (da) * 1985-04-22 1985-04-23 Novo Industri As Nitrogenholdige forbindelser
JPH0681745B2 (ja) * 1986-01-16 1994-10-19 シェリング・コ−ポレ−ション 縮合ベンゾアゼピン
EP0244088A3 (en) * 1986-04-03 1989-03-15 Smithkline Beecham Corporation 1-phenyl-3-benzazepine compounds and medicaments containing these compounds for treating gastrointestinal motility disorders

Also Published As

Publication number Publication date
DE68913367D1 (de) 1994-04-07
IL90533A0 (en) 1990-01-18
NO892476D0 (no) 1989-06-14
JP2769718B2 (ja) 1998-06-25
US5010074A (en) 1991-04-23
AU622911B2 (en) 1992-04-30
FI892946A0 (fi) 1989-06-15
US5025009A (en) 1991-06-18
NO173865B (no) 1993-11-08
NO892476L (no) 1989-12-18
NZ229521A (en) 1991-12-23
FI892946A7 (fi) 1989-12-16
PT90883A (pt) 1989-12-29
NO173865C (no) 1994-02-16
EP0347672A1 (en) 1989-12-27
FI93354C (fi) 1995-03-27
ES2061794T3 (es) 1994-12-16
ATE102188T1 (de) 1994-03-15
IE891932L (en) 1989-12-15
FI93354B (fi) 1994-12-15
DK325188D0 (da) 1988-06-15
DE68913367T2 (de) 1994-06-01
JPH0240364A (ja) 1990-02-09
EP0347672B1 (en) 1994-03-02
PT90883B (pt) 1994-12-30
AU3635989A (en) 1989-12-21
CA1317938C (en) 1993-05-18

Similar Documents

Publication Publication Date Title
EP0170213B1 (en) Glutarimide antianxiety and antihypertensive agents
EP0492485B1 (en) N-Acyl-2,3-benzodiazepine derivatives, pharmaceutical compositions containing them and process for preparing same
US3420851A (en) Novel dibenzoxepines
US4556653A (en) Pyrido[1,5]benzodiazepinone derivatives and pharmacological activities thereof
GB1583352A (en) 1,2-dihydronaphthalene derivatives and production thereof
Chapleo et al. Heteroaromatic analogs of the. alpha. 2-adrenoreceptor partial agonist clonidine
US5010074A (en) Novel benzazepine derivatives
IE58883B1 (en) Nitrogen containing compounds
US5498628A (en) Naphthamide derivatives
US4612312A (en) Glutarimide antianxiety and antihypertensive agents
FI63402B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara d- och d1-trans-5-fenyl-2,3,4,4a 5,9b-hexahydro-1h-pyrido(4,3-b)indolderivat
FR2850654A1 (fr) Nouveaux derives d'azepines tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA1207774A (en) 1-phenylindazol-3-one compounds, a method of preparing them and pharmaceutical compositions containing these compounds
HK24194A (en) Pyrrolo[1,2-a][4,1]benzoxazepines, process for their preparation, pharmaceutical compositions containing these compounds and therapeutical use
FI113770B (fi) Menetelmä farmakologisesti aktiivisten 5-(2,3-dihydrobentsofuran-7-yyli)-7-hydroksi-3-metyyli-2,3,4,5-tetrahydro-1H-3-bentsatsepiinien valmistamiseksi
CA1133483A (en) Hexahydro-trans-pyridoindole neuroleptic agents
HK57297A (en) Morpholine derivatives, their process of preparation and pharmaceutical compositions containing them
HU193711B (en) Process for preparing benzazepine derivatives
US4013679A (en) Substituted 6,7-dihydro [1,7-ab](1) benzazepine compounds
FI63578C (fi) Analogifoerfarande foer framstaellning av nya farmakologiskt verksamma 1,3,4,14b-tetrahydro-2h 10h-pyrazino(1,2-a)pyrrolo(2,1-c)(1,4)bensodiazepiner
JPS62249984A (ja) Ｄ−ノル−７−エルゴリン誘導体、その製法、薬剤組成物及び使用
DK163993B (da) 5,7,8-substituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner, fremstilling af disse, samt farmaceutiske praeparater indeholdende disse
US4318909A (en) Benzoxazocines
US4626522A (en) Benzoxazocines intermediates
JPH03197463A (ja) 新規ベンズアゼピン

Legal Events

Date Code Title Description
KB Patent renewed
HP Change in proprietorship
KB Patent renewed
HP Change in proprietorship
KB Patent renewed